Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01507571
Other study ID # DignityTherapyDK 01
Secondary ID PP04011
Status Completed
Phase Phase 2
First received November 11, 2011
Last updated January 10, 2012
Start date September 2005
Est. completion date September 2007

Study information

Verified date January 2012
Source Bispebjerg Hospital
Contact n/a
Is FDA regulated No
Health authority Denmark: The Regional Committee on Biomedical Research EthicsDenmark: Danish Dataprotection Agency
Study type Interventional

Clinical Trial Summary

The purpose of the study is to investigate whether Danish patients with incurable cancer have a need of, interest in and benefit from Dignity Therapy.


Description:

Research in palliative care has primarily focused on physical and psychological symptoms. Research in other psychosocial and existential problems has been sparse. Loss of dignity as a consequence of serious illness may be an important cause of suffering. The research team of the Canadian psychiatrist and professor, Harvey Chochinov has investigated the concept of dignity and developed the psychosocial intervention 'Dignity Therapy' (DT). The preliminary research results were promising.

Research questions: Do Danish cancer patients have a need of, interest in, and benefit from DT? Methods: DT consists of an interview revolving around the patient's life, values, and accomplishments and is also an opportunity to leave messages and words of hope and compassion for friends and family. The interview is audio taped, transcribed, and edited together with the patient, and made into a tangible document, which the patient can give to his/her relatives. The project consists of three parts: (1) a cross-sectional investigation of the prevalence of loss of dignity and related symptoms/problems among at least 200 incurable cancer patients. (2) A feasibility study, testing the intervention in terms of relevance and the need of any modifications in relation to Danish patients. (3) An evaluation study testing the effect of and satisfaction with DT.

At least 80 patients are planned for the feasibility and evaluation studies. Questionnaires are used for detection of loss of dignity and as measures of effect. These will be administered before the intervention and, along with a semi-structured evaluation questionnaire, right after the intervention, when the document is received and again approximately two weeks later.

The duration of the intervention (DT) varies markedly between patients. In some cases the process (interview, transcription, editing of document, and the final meeting where the document is given back to the patient) is completed urgently in a few days, whereas in other cases, the patient prefers a slower pace, and may want to sub-divide the interview into two or more parts. Also, when presented with the document, some patients want to have something changed or they want add material. This variation is seen as intentional, as it illustrates that the process is tailored to the patient's wishes.

As stated, the effect of the DT intervention is evaluated at completion of the intervention, i.e. when the final document is given back to the patient, and about two weeks later. Due to process described above, the time from the first measurement (before intervention) to the second measurement (which takes places at completion of the intervention) therefore varies considerably (median 36 days after baseline, range 7-121 days).

Perspective: If Danish patients have a need of, an interest in and benefit from DT, it can be offered to Danish patients admitted to palliative care.


Recruitment information / eligibility

Status Completed
Enrollment 80
Est. completion date September 2007
Est. primary completion date September 2007
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- diagnosis of incurable cancer,

- 18 years or older,

- informed of diagnosis and the incurable prognosis.

Exclusion Criteria:

- dementia and other cognitive impairment,

- physical limitations,

- sufficient to preclude participation.

Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care


Related Conditions & MeSH terms


Intervention

Other:
Dignity Therapy
Dignity Therapy is a brief psychotherapeutic intervention consisting of: a tape-recorded session with the patient using the DT question protocol Transcription of the interview, which is then edited A session where the edited transcript is returned to the patient who can give it to family members or friends. If needed, one or more sessions are added. Dt allows the patient to give voice to the matters of importance concerning himself and his loved ones. Its purpose is to enhance sense of meaning, purpose and worth. It also gives the opportunity to leave something behind to be remembered by.

Locations

Country Name City State
Denmark Department of Palliative Medicine Copenhagen
Denmark Sankt Lukas Hospice Hellerup

Sponsors (1)

Lead Sponsor Collaborator
Bispebjerg Hospital

Country where clinical trial is conducted

Denmark, 

References & Publications (1)

Houmann LJ, Rydahl-Hansen S, Chochinov HM, Kristjanson LJ, Groenvold M. Testing the feasibility of the Dignity Therapy interview: adaptation for the Danish culture. BMC Palliat Care. 2010 Sep 22;9:21. doi: 10.1186/1472-684X-9-21. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Sense of dignity Measured with the Structured Interview for Symptoms and Concerns (SISC) Pre-post intervention (when the document was recieved by the patient), and again two weeks later. No
Secondary Hopelessness Measured with the Structured Interview for Symptoms and Concerns (SISC) Pre-post intervention (when the document was recieved by the patient), and again two weeks later. No
Secondary Anxiety Measured on the Hospital anxiety and depression scale Pre-post intervention (when the document was received by the patient), and again two weeks later. No
Secondary Depression Measured on the Hospital Anxiety and Depression scale Pre-post intervention (when the document was received by the patient), and again two weeks later. No
Secondary Not able to perform tasks of daily living Measured on the Patient Dignity Inventory Pre-post intervention (when the document was received by the patient), and again two weeks later. No
Secondary Suffering Measured with the Structured Interview for Symptoms and Concerns Pre-post intervention (when the document was received by the patient), and again two weeks later. No
Secondary performance status Measured on the Palliative Performance Scale v2 Pre-post intervention (when the document was received by the patient), and again two weeks later. No
Secondary Communication Measured on the Structured Interview for Symptoms and Concerns Pre-post intervention (when the document was received by the patient), and again two weeks later. No
Secondary Social Contact Measured on the Structured Interview for Symptoms and Concerns Pre-post intervention (when the document was received by the patient), and again two weeks later. No
Secondary Depression Measured with the Structured Interview for Symptoms and Concerns Pre-post intervention (when the document was received by the patient), and again two weeks later. No
Secondary Not able to attend to bodily functions Item from the Patient Dignity Inventory Pre-post intervention (when the document was received by the patient), and again two weeks later. No
Secondary Physically distressing symptoms Item from the Patient Dignity Inventory Pre-post intervention (when the document was received by the patient), and again two weeks later. No
Secondary Feeling how I look has changed Item from the Patient Dignity Inventory Pre-post intervention (when the document was received by the patient), and again two weeks later. No
Secondary Feeling depressed Item from the Patient Dignity Inventory Pre-post intervention (when the document was received by the patient), and again two weeks later. No
Secondary Feeling anxious Item from the Patient Dignity Inventory Pre-post intervention (when the document was received by the patient), and again two weeks later. No
Secondary Feeling uncertain Item from the Patient Dignity Inventory Pre-post intervention (when the document was received by the patient), and again two weeks later. No
Secondary Worried about future Item from the Patient Dignity Inventory Pre-post intervention (when the document was received by the patient), and again two weeks later. No
Secondary Not able to think clearly Item from the Patient Dignity Inventory Pre-post intervention (when the document was received by the patient), and again two weeks later. No
Secondary Not able to continue usual routines Item from the Patient Dignity Inventory Pre-post intervention (when the document was received by the patient), and again two weeks later. No
Secondary Feeling no longer who I was Item from the Patient Dignity Inventory Pre-post intervention (when the document was received by the patient), and again two weeks later. No
Secondary Not feeling worthwhile or valued Item from the Patient Dignity Inventory Pre-post intervention (when the document was received by the patient), and again two weeks later. No
Secondary Not able to carry out important roles Item from the Patient Dignity Inventory Pre-post intervention (when the document was received by the patient), and again two weeks later. No
Secondary Feeling life no longer has meaning or purpose Item from the Patient Dignity Inventory Pre-post intervention (when the document was received by the patient), and again two weeks later. No
Secondary Feeling of not having made a meaningful contribution Item from the Patient Dignity Inventory Pre-post intervention (when the document was received by the patient), and again two weeks later. No
Secondary Feeling of unfinished business Item from the Patient Dignity Inventory Pre-post intervention (when the document was received by the patient), and again two weeks later. No
Secondary Concerns regarding spiritual life Item from the Patient Dignity Inventory Pre-post intervention (when the document was received by the patient), and again two weeks later. No
Secondary Feeling like a burden to others Item from the Patient Dignity Inventory Pre-post intervention (when the document was received by the patient), and again two weeks later. No
Secondary Feeling of not having control Item from the Patient Dignity Inventory Pre-post intervention (when the document was received by the patient), and again two weeks later. No
Secondary Feeling of reduced privacy Item from the Patient Dignity Inventory Pre-post intervention (when the document was received by the patient), and again two weeks later. No
Secondary Not feeling supported by friends or family Item from the Patient Dignity Inventory Pre-post intervention (when the document was received by the patient), and again two weeks later. No
Secondary Not feeling supported by health care providers Item from the Patient Dignity Inventory Pre-post intervention (when the document was received by the patient), and again two weeks later. No
Secondary Not feeling able to mentally fight illness Item from the Patient Dignity Inventory Pre-post intervention (when the document was received by the patient), and again two weeks later. No
Secondary Not being able to accept things as they are Item from the Patient Dignity Inventory Pre-post intervention (when the document was received by the patient), and again two weeks later. No
Secondary Not being treated with respect Item from the Patient Dignity Inventory Pre-post intervention (when the document was received by the patient), and again two weeks later. No
Secondary Physical function Measured on the EORTC QLQ-C15-PAL Pre-post intervention (when the document was received by the patient), and again two weeks later. No
Secondary Emotional function Measured on the EORTC QLQ-C15-PAL Pre-post intervention (when the document was received by the patient), and again two weeks later. No
Secondary Overall quality of life Measured on the EORTC QLQ-C15-PAL Pre-post intervention (when the document was received by the patient), and again two weeks later. No
Secondary Fatigue Measured on the EORTC QLQ-C15-PAL Pre-post intervention (when the document was received by the patient), and again two weeks later. No
Secondary Nausea / Vomiting Measured on the EORTC QLQ-C15-PAL Pre-post intervention (when the document was received by the patient), and again two weeks later. No
Secondary Pain Measured on the EORTC QLQ-C15-PAL Pre-post intervention (when the document was received by the patient), and again two weeks later. No
Secondary Dyspnoea Measured on the EORTC QLQ-C15-PAL Pre-post intervention (when the document was received by the patient), and again two weeks later. No
Secondary Insomnia Measured on the EORTC QLQ-C15-PAL Pre-post intervention (when the document was received by the patient), and again two weeks later. No
Secondary Appetite loss Measured on the EORTC QLQ-C15-PAL Pre-post intervention (when the document was received by the patient), and again two weeks later. No
Secondary Constipation Measured on the EORTC QLQ-C15-PAL Pre-post intervention (when the document was received by the patient), and again two weeks later. No
See also
  Status Clinical Trial Phase
Recruiting NCT05346796 - Survivorship Plan HEalth REcord (SPHERE) Implementation Trial N/A
Recruiting NCT05094804 - A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents Phase 1/Phase 2
Completed NCT04867850 - Effect of Behavioral Nudges on Serious Illness Conversation Documentation N/A
Enrolling by invitation NCT04086251 - Remote Electronic Patient Monitoring in Oncology Patients N/A
Completed NCT01285037 - A Study of LY2801653 in Advanced Cancer Phase 1
Completed NCT00680992 - Study of Denosumab in Subjects With Giant Cell Tumor of Bone Phase 2
Completed NCT00062842 - Study of Irinotecan on a Weekly Schedule in Children Phase 1
Active, not recruiting NCT04548063 - Consent Forms in Cancer Research: Examining the Effect of Length on Readability N/A
Completed NCT04337203 - Shared Healthcare Actions and Reflections Electronic Systems in Survivorship N/A
Recruiting NCT04349293 - Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways N/A
Terminated NCT02866851 - Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy N/A
Active, not recruiting NCT05304988 - Development and Validation of the EFT for Adolescents With Cancer
Completed NCT04448041 - CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
Completed NCT00340522 - Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Active, not recruiting NCT03844048 - An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial Phase 3
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Completed NCT03109041 - Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source Phase 1
Terminated NCT01441115 - ECI301 and Radiation for Advanced or Metastatic Cancer Phase 1
Recruiting NCT06206785 - Resting Energy Expenditure in Palliative Cancer Patients